Cours Acro Biomedical Co., Ltd. Other OTC
Actions
ACBM
US0048921052
Transformation des aliments
CA 2021 | 1,2 M 1,09 M | CA 2022 | 658 k 600 k | Capitalisation | 270 M 246 M |
---|---|---|---|---|---|
Résultat net 2021 | -7 M -6,37 M | Résultat net 2022 | -15 M -13,66 M | VE / CA 2021 | 233 x |
Trésorerie nette 2021 | 24,08 k 21,92 k | Dette nette 2022 | 98,69 k 89,86 k | VE / CA 2022 | 410 x |
PER 2021 |
-32,5
x | PER 2022 |
-17
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 50,03% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30/01/17 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30/01/17 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+17,57% | 8,44 Md | |
+3,57% | 7,47 Md | |
+5,65% | 6,31 Md | |
-5,39% | 3,77 Md | |
-2,14% | 1,33 Md | |
-28,77% | 1,09 Md | |
+15,61% | 988 M | |
-8,90% | 927 M | |
-16,80% | 801 M |